Filter
534
Filtered Results: 534
Text search:
XDR-TB
Featured
Recommendations
64
New Publications
140
Language
Document type
No document type
384
Guidelines
45
Studies & Reports
44
Manuals
17
Strategic & Response Plan
13
Situation Updates
12
Fact sheets
9
Training Material
8
Resource Platforms
1
Infographics
1
Countries / Regions
Western and Central Europe
50
Eastern Europe
34
India
22
South Africa
19
Latin America and the Carribbean
15
Kenya
11
Namibia
11
Nepal
9
Tanzania
9
Bangladesh
9
Colombia
8
Uganda
8
Peru
7
Ukraine
6
Asia
6
Germany
6
Russia
6
Ethiopia
6
Myanmar / Burma
6
Global
5
Argentina
5
Senegal
4
Bolivia
4
Botswana
4
Zambia
4
Ecuador
4
Lesotho
3
Ghana
3
Malawi
3
Mozambique
3
Armenia
3
Paraguay
3
Eswatini/ Swaziland
3
Tajikistan
2
El Salvador
2
Sierra Leone
2
Philippines
2
Africa
2
Venezuela
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Turkmenistan
2
Vietnam
2
Brazil
2
Georgia
2
Indonesia
2
Madagascar
2
Timor Leste/ East Timor
1
Gambia
1
Rwanda
1
Kazakhstan
1
Cameroon
1
Nigeria
1
Albania
1
Estonia
1
Afghanistan
1
Cambodia
1
Dominican Republic
1
Congo, Democratic Republic of
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Azerbaijan
1
Belarus
1
East and Southern Africa
1
Moldova
1
Sri Lanka
1
Romania
1
Bhutan
1
South Sudan
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
205
Clinical Guidelines
59
Public Health
12
Capacity Building
9
Pharmacy & Technologies
6
Key Resources
5
Women & Child Health
1
Toolboxes
TB
340
HIV
39
AMR
23
Polio
11
Refugee
8
Caregiver
5
Ebola
4
Pharmacy
4
Rapid Response
3
COVID-19
3
NTDs
3
Specific Hazards
1
Disability
1
Conflict
1
Global Health Education
1
The End TB Strategie
Anti-tuberculosis drug resistance among tuberculosis patients in Ukraine and risk factors for MDR-TB
Results of the first national survey, 2013–2014
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate...
The first important change is a new priority ranking of the available medicines for MDR-TB treatment, based on a careful balance between expected benefits and harms. Treatment success for MDR-TB is currently low in many countries. This could be increased by improving access to the highest-ranked med...
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages of 10–19 years, adolescents are both at risk of TB and...
Цель этого документа – повысить уровень осознания актуальности приоритетных направлений научных исследований по проблеме ТБ/ВИЧ (то есть по тем направлениям, кот...
6th edition
Apart from implementation of TB infection Prevention and Control measures, treatment of those with active TB of the lungs is key in preventing the spread of the TB bacilli. The Public Health Act CAP 242, section 17 classify TB as notifiable infectious disease and under section 26 as part of preventi...
Um Manual Programático
A publicação deste documento foi possível graças ao apoio da Comissão Europeia (auxílio Sante 2007141-838). O conteúdo deste documento é de responsabilidade única de A Union e não reflete a opinião da Comissão Europeia.
Una Guía Programática
San José, Costa Rica, Noviembre 4–5 noviembre 2008
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-gamma release assays (IGRA) are also valid for Beij...
